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ABSTRACT Considerable evidence exists that bacteria detect eukaryotic communicationmolecules andmodify their virulence
accordingly. In previous studies, it has been demonstrated that the increasingly antibiotic-resistant pathogen Pseudomonas
aeruginosa can detect the human hormones brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) at micromolar
concentrations. In response, the bacteriummodifies its behavior to adapt to the host physiology, increasing its overall virulence.
The possibility of identifying the bacterial sensor for these hormones and interfering with this sensing mechanism offers an ex-
citing opportunity to directly affect the infection process. Here, we show that BNP and CNP strongly decrease P. aeruginosa bio-
film formation. Isatin, an antagonist of human natriuretic peptide receptors (NPR), prevents this effect. Furthermore, the hu-
man NPR-C receptor agonist cANF4-23 mimics the effects of natriuretic peptides on P. aeruginosa, while sANP, the NPR-A
receptor agonist, appears to be weakly active. We show in silico that NPR-C, a preferential CNP receptor, and the P. aeruginosa
protein AmiC have similar three-dimensional (3D) structures and that both CNP and isatin bind to AmiC.We demonstrate that
CNP acts as an AmiC agonist, enhancing the expression of the ami operon in P. aeruginosa. Binding of CNP and NPR-C agonists
to AmiC was confirmed bymicroscale thermophoresis. Finally, using an amiCmutant strain, we demonstrated that AmiC is es-
sential for CNP effects on biofilm formation. In conclusion, the AmiC bacterial sensor possesses structural and pharmacological
profiles similar to those of the human NPR-C receptor and appears to be a bacterial receptor for human hormones that enables
P. aeruginosa to modulate biofilm expression.
IMPORTANCE The bacterium Pseudomonas aeruginosa is a highly dangerous opportunist pathogen for immunocompromised
hosts, especially cystic fibrosis patients. The sites of P. aeruginosa infection are varied, with predominance in the human lung, in
which bacteria are in contact with host molecular messengers such as hormones. The C-type natriuretic peptide (CNP), a hor-
mone produced by lung cells, has been described as a bacterial virulence enhancer. In this study, we showed that the CNP hor-
mone counteracts P. aeruginosa biofilm formation and we identified the bacterial protein AmiC as the sensor involved in the
CNP effects. We showed that AmiC could bind specifically CNP. These results show for the first time that a human hormone
could be sensed by bacteria through a specific protein, which is an ortholog of the human receptor NPR-C. The bacteriumwould
be able to modify its lifestyle by favoring virulence factor production while reducing biofilm formation.
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Pseudomonas aeruginosa is a well-known opportunistic patho-gen and a major cause of mortality among cystic fibrosis pa-
tients (1). The morbidity associated with this bacterium and its
resistance to antibiotherapy are largely attributed to its transition
in host tissues (particularly in lung, soft tissues, skin, and urinary
bladder) from a planktonic to a biofilm lifestyle (2, 3). The present
emergence of multiresistant strains is now critical and is prompt-
ing the need to find new therapeutic approaches (4).
The high adaptability of P. aeruginosa and its rapid response to
the host environment imply that it can detect a large range of
eukaryotic chemical signals (5).However, fewbacterial sensors for
eukaryotic molecules have been characterized to date (6). Studies
on the Escherichia coli quorum-sensing regulator A (QseA) led to
the identification of QseC/QseB, a two-component regulatory
system (7, 8). This system is activated not only by the bacterial
quorum-sensing signal autoinducer AI3 but also by eukaryotic
neurohormones (epinephrine/norepinephrine) (9). It was sug-
gested that QseC could be a bacterial ortholog of eukaryotic ad-
renergic receptors (10). Bioinformatic screening of E. coli QseC
analogs has demonstrated the presence of proteins related to this
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sensor in a large number of bacterial pathogens, including
P. aeruginosa (11), in which norepinephrine acts as a virulence
inducer (12). It appears that P. aeruginosa is able to sense different
eukaryotic communication molecules, including gamma inter-
feron (13), dynorphin (14), gamma aminobutyric acid (GABA)
(15), and natriuretic peptides (16, 17).
Natriuretic peptides are a family of eukaryotic hormones and
neurohormones composed of three members: atrial natriuretic
peptide (ANP), brain natriuretic peptide (BNP), and C-type na-
triuretic peptide (CNP). These peptides are mainly expressed in
cardiomyocytes and endothelial cells (18) explaining their major
role in cardiovascular homeostasis. However, ANP and CNP are
also produced in significant amounts by the lung bronchial and
alveolar epithelia and particularly by Clara (Club) cells (19). The
circulating blood levels of natriuretic peptides are increased dur-
ing community-acquired pneumonia (20), and the lipopolysac-
charides (LPS) of Gram-negative bacteria induces the plasmatic
release of both BNP (21) and CNP (22). In previous studies, we
demonstrated that P. aeruginosa can detect BNP and CNP at mi-
cromolar concentrations and reacts with an overall increase of
virulence (16, 17). InP. aeruginosa, the effect of CNP appears to be
mediated by cyclic AMP (cAMP) synthesis, which subsequently
activates the regulatory proteins Vfr (17) and PtxR (16), leading to
a rise of HCN and exotoxin A production and a reorganization of
LPS structure. For these reasons, it was suggested that CNP pro-
motes the acute infection phenotype of P. aeruginosa (23), favor-
ing the switch of P. aeruginosa to a planktonic lifestyle, and a
decrease in biofilm formation. The effects of BNP and CNP on
P. aeruginosa appear to bemediated by distinctmechanisms, since
BNP, unlike CNP, did not modify intrabacterial cAMP levels (17)
and was without effect on P. aeruginosa virulence for Caenorhab-
ditis elegans (16). In humans, each type of natriuretic peptide acts
through a particular receptor subtype, suggesting the expression
of specific bacterial orthologs of the human natriuretic peptide
receptors in P. aeruginosa.
In the present study, we extended our knowledge of the effect
of natriuretic peptides on P. aeruginosa by investigating for the
first time the effect of these peptides on the biofilm formation
activity of the bacterium. Using in silico approaches, we identified
the P. aeruginosa protein AmiC as a potential CNP binding sensor
site and investigated in vitro the binding of natriuretic peptide
receptor agonists to AmiC. The pharmacological profile of AmiC
as a bacterial CNP receptor was completed by studying the effect
of isatin, an antagonist of human CNP receptors that is also a
known bacterial metabolite and signaling compound. We further
determined the affinity of AmiC for several natriuretic peptide
receptor agonists. Using an amiC-deficient mutant and its com-
plemented derivative, we validated the crucial role ofP. aeruginosa
AmiC in the effect of CNP, but not BNP, on biofilm formation.
This study provides an integrated explanation of the CNP sensing
system in P. aeruginosa and opens up the way to develop a new
strategy to control P. aeruginosa biofilm formation.
RESULTS
Effects of CNP and BNP on P. aeruginosa biofilm formation.
The influence of CNP and BNP on the biofilm formation activity
of P. aeruginosawas investigated under dynamic and static condi-
tions. Unless otherwise stated, peptides were used at amicromolar
concentration, since (i) this corresponds to the concentration
usually used for studying the effects of peptides on eukaryotic
models (24), (ii) the peptideswere previously shown to be active at
this concentration on quorum-sensing molecules and toxin pro-
duction in P. aeruginosa (16), and (iii) the duration of the biofilm
experiment, which required a large amount of medium (continu-
ous flow) containing the peptides, was not compatible with the
realization of a whole dose-response study. When P. aeruginosa
PA14 was exposed to CNP or BNP under dynamic conditions, we
observed a highly significant decrease of the biofilm volume
(81.0%  6.6% and 80.3%  4.4%, respectively; P  0.001)
and of the biofilm average thickness (72.3 9.7% and76.0
4.8%, respectively; P 0.001) (Fig. 1A). These effects were asso-
ciated with a reduction of the number and mean size of
mushroom-like structures in the biofilm (Fig. 1B). Exposure of
P. aeruginosaMPAO1 to CNP for 24 h under static conditions led
to similar results, with a marked decrease of biofilm formation
(Fig. 2A) associated with a reduction of volume and thickness
(83.3  1.9% and 91.7  2.2%, respectively; P  0.001)
(Fig. 2B).
Effects of specific antagonist and agonists of natriuretic pep-
tide receptors onP. aeruginosabiofilm formation and virulence
activity. The biofilm formation activity of P. aeruginosa MPAO1
FIG 1 Biofilm formation by Pseudomonas aeruginosa PA14 exposed to C-type
natriuretic peptide (CNP) or brain natriuretic peptide (BNP) in dynamic con-
dition. (A) COMSTAT analyses of biofilms of P. aeruginosa PA14 control
(PA14) or PA14 exposed to CNP (106 M) or BNP (106 M). Data are the
means for twelve samples from six independent experiments for control bac-
teria, ten samples from six independent experiments for CNP-exposed bacte-
ria, and six samples from two independent experiments for BNP-exposed bac-
teria. ***, P 0.001. (B) 3D shadow representations of the biofilm structures
developed under dynamic condition by P. aeruginosa PA14 control or PA14
exposed to CNP or exposed to BNP at 37°C for 24 h in LB broth. Biofilms were
stained with Syto 61 red dye or SytoX dye and observed by confocal laser
scanning microscopy.
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was also studied in the presence of isatin, an antagonist of both A
and C subtypes natriuretic peptide receptors (NPR-A and NPR-
C). Administered alone for 24 h, isatin affected the organization of
the biofilm, which appeared to be more irregular, with the pres-
ence of large water channels (Fig. 2A).We also noted a limited and
nonsignificant increase of the biomass and thickness of the biofilm
(Fig. 2B). However, when P. aeruginosa MPAO1 was exposed to
isatin (105M) for 20min prior to the administration of CNP, the
inhibitory effect of CNP on the biofilm formation activity of the
bacterium was abolished (Fig. 2A and B).
As we had previously shown that natriuretic peptides enhance
P. aeruginosa cytotoxicity activity and global virulence (16), we
tested the effects of sANP, a specific NPR-A agonist, and the arti-
ficial peptide cANF4-23, a specific NPR-C agonist, on bacterial cy-
totoxicity for lung cells. The peptide cANF4-23 (anNPR-C agonist)
caused a strong increase of P. aeruginosa cytotoxicity activity
against A549 human lung epithelial cells (98.3% 16.9%; P
0.001) (Fig. 2C). In parallel, we observed that the sANP peptide
(an NPR-A agonist) also enhanced the P. aeruginosa cytotoxicity
in the same cell model, but to a lower extent (25.9%  12.1%;
P 0.05) (Fig. 2C).
In silico study of a functional C-type natriuretic peptide re-
ceptor ortholog in P. aeruginosa. Inmammalian cells, CNP pref-
erentially binds theNPR-C receptor and has a weak affinity for the
NPR-A receptor (25), whereas BNP strongly bindsNPR-A andhas
a weak affinity for NPR-C. The observations that the effects of
FIG 2 Effect of antagonists and agonists of natriuretic peptide receptors. (A) 2D black-and-white images resulting from CLSM observations of MPAO1 24-h
biofilms obtained under static conditions after growth under control conditions and exposed to CNP (106 M), isatin (105 M) or both isatin and CNP. (B)
COMSTAT analyses of biofilms of P. aeruginosa MPAO1 exposed to CNP, to isatin, or both to isatin and CNP. Data are means from three independent
experiments for CNP exposure and two independent experiments for isatin and isatin-plus-CNP exposure. ***, P 0.001; NS, not significantly different. (C)
Cytotoxic activity of PA14 alone (control), PA14 exposed to the NPR-C agonist cANF4-23 (106M), or PA14 exposed to the NPR-A agonist sANP (106M). The
cytotoxic effect of the bacteriumwas determined bymeasuring lactate dehydrogenase (LDH) accumulation in themedium. Data are themeans for nine samples
from three independent experiments for cANF4-23 and means for six samples from two independent experiments for sANP. ***, P 0.001; **, P 0.01; *, P
0.05.
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CNP were blocked by the NPR-C antagonist isatin and mimicked
by the NPR-C agonist cANF4-23 suggested the presence of a bac-
terial ortholog of NPR-C in P. aeruginosa. This hypothesis was
investigated using in silico approaches. Searching bibliographic
data, we noted a DALI structure similarity search (26) that iden-
tified a P. aeruginosa protein, AmiC, which shows structural ho-
mologies with the binding domain of natriuretic peptides recep-
tors (27, 28). Using tools from the Protein Data Bank in Europe
(http://www.ebi.ac.uk/pdbe/), we investigated in detail the struc-
ture of P. aeruginosa AmiC bound to its known ligand acetamide.
We observed that it shares high structural similarity with the na-
triuretic peptide receptor subtypeNPR-C bound to one of its ago-
nists, the atrial natriuretic peptide (ANP) (data not shown). This
supports the hypothesis that AmiC could act as a bacterial natri-
uretic peptide sensor.
The three-dimensional (3D) structure of P. aeruginosa AmiC
(Protein Data Bank [PDB] ID: 1PEA) (29) was compared to that
of the human NPR-C receptor (hNPR-C) (PDB ID: 1JDP) (30).
Using the STAMP software (31), we superimposed an AmiC
monomer onto each protomer of the structure of an hNPR-C
dimer in complex with CNP. Although the sequences of these
proteins share only 19% identity and 26% similarity, these two
proteins present an overall similar 3D structure in the homodi-
meric form (Fig. 3A), particularly at the interface between mono-
mers, which is considered the binding cleft of hNPR-C. The high-
est similarity was found in the helix of AmiC, corresponding to the
region involved in the binding of CNP to hNPR-C. Next, we split
the AmiC monomer into two parts, corresponding to the two
lobes of the protein. The first lobe consists of amino acids 8 to 123
and 261 to 338, and the second lobe consists of amino acids 124 to
260 and 339 to 375 of AmiC. Then, we superimposed each lobe on
the 3D structure of hNPR-C (Fig. 3B). Each lobe of hNPR-C and
AmiC showed a high level of secondary structure conservation
with similar 3D positions, reinforcing the concept of structural
homology between these two proteins. Using GASH structural
superposition software (32) on each lobe of hNPR-C and AmiC,
we observed that each of these two proteins has 254 residues esti-
mated to be involved in equivalent secondary structures, covering
61.7% of the AmiC sequence. The hinge between the two lobes
was essentially formed with flexible loops. Once the structures
were superimposed, we looked at the amino acids involved in the
binding of CNP, supporting the hypothesis that AmiC and
hNPR-C bind the peptide in a similar fashion. Table S1 in the
supplemental material lists AmiC amino acids that are potentially
involved in CNP binding and the corresponding amino acids in-
volved in the binding of hNPR-C to CNP, as described byHe et al.
(33). Amino acids locatedwithin 4ÅofCNP in the binding sites of
both hNPR-C and AmiC are shown schematically in Fig. S1 in the
supplemental material. A total of 24 amino acids from AmiC and
21 residues from hNPR-C with equivalent physicochemical prop-
erties are located in the same regions andmay stabilize the binding
of CNP to AmiC and NPR-C equivalently.
We also determined the virtual capacity of P. aeruginosa AmiC
to bind natriuretic peptides (BNP and CNP) by molecular dock-
ing using AutoDock (34). Docking revealed that CNP can bind to
AmiC at the dimer interface of the bacterial protein (see Fig. S2A
and B in the supplemental material). Themost relevant calculated
binding site of CNP on AmiC requires 13 amino acids: Arg64,
Glu68, Ala90, Met92, Pro93, Glu96, Arg97, Asp99, Glu112,
Tyr113, Pro115, Asn116, andTyr366. Since these predictionswere
obtained by an in silico study, the involvement of each of these
residues needs to be validated by constructing and studying the 13
correspondent mutant proteins, which will be addressed in a fu-
ture work. In contrast, we observed in silico that BNP has no af-
finity for the AmiC protein. The NPR-C antagonist isatin also
appeared capable of binding to the AmiC dimer interface (see
Fig. S2C andD). In this case, theAmiC amino acids involved in the
recognition of isatin are predicted to be Ile71, Arg72, Val94, and
Arg97. These amino acids are located in the same region involved
as the putative CNP binding site, and one residue (Arg97) could
play a key role, since it potentially interacts with both CNP and
isatin.
Effect of CNP on the expression of the amidase operon in
P. aeruginosa. In P. aeruginosa, AmiC is considered a sensor pro-
tein. In the absence of stimulation (basal conditions), AmiC binds
to the AmiR protein, an antitermination factor, which down-
regulates the transcription of the amiEBCRS operon (35). Upon
binding of acetamide, AmiC releases AmiR, triggering the tran-
scription of the whole ami operon (36). In order to verify that
CNP could act in the same manner as acetamide on AmiC, we
measured amiB, amiC, amiE, and amiR mRNA levels by quanti-
tative reverse transcription-PCR (qRT-PCR) 1 h after exposure of
the bacterium to CNP. The amiC, amiE, and amiR mRNA levels
FIG 3 Cartoon representation of AmiC (PDB ID: 1PEA) (red) and hNPR-C
(PDB ID: 1JDP) (blue) superimposed using the STAMP algorithm. (A) Over-
all superimposition of AmiC and NPR-C, shown in cartoon form. The CNP
peptide is in green. (B) Superimposition by lobes of AmiC and hNPR-C. The
lobe on the left corresponds to amino acids 8 to 123 and 261 to 338 of AmiC,
and the lobe on the right corresponds to amino acids 124 to 260 and 339 to 375.
These images were made using VMD (63).
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were significantly increased (2.97-  0.2-, 3.66-  0.39-, and
2.73- 0.67-fold, respectively; P 0.001) after 1 h of exposure to
CNP (106 M) (Fig. 4), whereas the amount of lecB mRNA, en-
coded by a gene adjacent to the ami operon, was not modified. In
contrast, BNP (106M) had no significant effect on the whole ami
operon transcriptional activity (data not shown).
AmiC binding with natriuretic peptide receptor agonists. In
order to confirm that the action ofCNPand isatin onP. aeruginosa
ismediated directly throughAmiC and is not an indirect effect, we
investigated their binding to AmiC in vitro. Recombinant AmiC
was expressed in E. coli. We first confirmed the oligomeric state of
AmiC using native gel electrophoresis and analytical gel filtration
(see Fig. S3 in the supplemental material). Thesemethods showed
an apparent molecular mass of 120  30 kDa and 136  3 kDa,
respectively. These results are most consistent with AmiC
(protomer molecular mass, 45.5 kDa) forming a dimer with an
irregular shape, as predicted by the model (Fig. S3). We then
tested the interaction of AmiC with natriuretic peptide receptor
agonists and isatin using microscale thermophoresis (Fig. 5A).
AmiC bound to CNP tightly, showing a dissociation constant
(KD) of 2.0 0.3 M (Fig. 5). In contrast, we observed that BNP
possessed no affinity for AmiC (Fig. 5A). Isatin could also bind to
AmiC, although in this case, the interaction was not so strong,
showing a KD of 600 200 M (Fig. 5A and B). Additionally, we
measured the interactions of other natriuretic peptide receptor
agonists. sANP, a specific NPR-A agonist, showed a weak interac-
tion with AmiC which had clearly not proceeded to completion at
900 M (Fig. 5B), the highest concentration that we were able to
assess. These data clearly predict that the KD is greater than
600 M. Conversely, our initial experiments on osteocrin (a spe-
cificNPR-C agonist) showed a very strong interactionwith AmiC,
apparently tighter than we were able to determine using the avail-
able instrument. This indicates a KD value below 100 nM. In the
same way, cANF4-23, another NPR-C specific agonist, presented a
KD value of 40 10 M (Fig. 5).
Involvement of AmiC in CNP-regulated P. aeruginosa bio-
film formation. Under dynamic conditions, the biofilm formed by
thePA14amiC strain appeared reduced incomparison towild-type
strainPA14WT(Fig. 6A).Conversely, themorphologyof thebiofilm
formed by the PA14 AmiC strain (PA14 containing the wild-type
amiC geneplus extra amiCplasmid-borne copies) or by thePA14EV
strain carrying the empty vector was similar to that of the wild-type
(data not shown). Complementation of the amiC strain with the
amiC gene carried by a vector restored entirely the ability of the bac-
teria to form a biofilm (Fig. 6A and B). The measure of the biofilm
biovolumes revealed 64.5  12.5% reduction for the PA14 amiC
strain in comparison to the PA14 wild type (P 0.001), whereas the
biovolume of the biofilm generated by the complemented strain is
similar to that of wild-type PA14 (13.7% 14.6%) (Fig. 6B). The
biofilm formed by the strain PA14 AmiC was slightly, but nonsig-
nificantly, enhanced (Fig. 6B).
We observed that the ability of CNP to reduce biofilm forma-
tion is abolished in the amiC strain (Fig. 6A and C) and is re-
stored in the complemented strain (71.9% 12.7%) (P 0.01)
FIG 4 Effect of C-type natriuretic peptide (CNP) on expression level of genes
from the ami operon. Expression levels of ami genes in PAO1-treated bacteria
relative to those in non-PAO1-treated bacteria (control). RNAswere extracted
1 h after PAO1 exposure to physiologic solution (control) or CNP (106 M)
and assayed by quantitative real-time reverse transcription-PCR (qRT-PCR).
These data are the means from two independent experiments. ***, P 0.001;
NS, not significantly different.
FIG 5 CNP, BNP, andNPR agonist and isatin affinities for AmiC in vitro. (A)
Recombinant AmiCwas fluorescently labeled and incubatedwith various con-
centrations of natriuretic peptide receptor agonists and isatin. These mixtures
were then analyzed using bymicroscale thermophoresis. The results were nor-
malized to a fitted zero for unbound AmiC, and the thermophoresis signal is
shown, in parts per thousand. Addition of cANF4-23 causedAmiCfluorescence
to increase in a dose-dependent fashion; this increase was used as the signal
rather than thermophoresis, as the effect confounds the thermophoresis sig-
nal. (B) The results were fitted to the dissociation constant formula from the
law of mass action. The fitted values for KD are shown for isatin, BNP, sANP,
cANF4-23, and osteocrin. We showed that these compounds either bound very
weakly (sANP), bound more tightly (osteocrin), or exhibited no interaction
(BNP). The data are the means from three independent experiments.
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(Fig. 6C). In contrast, BNP, which strongly reduced biofilm for-
mation aswell (75.1% 9.9%) (P 0.001) (Fig. 6C), continued
to have the same impact on biofilm formation in the amiCmu-
tant strain (70.8% 12.1%) (P 0.05) (Fig. 6C).
In parallel, since it had been shown previously that CNP also
modifies P. aeruginosa virulence, we tested the effect of AmiC on
cytotoxicity for lung cells. We observed that, whereas the PA14
wild-type strain showed an increase in cytotoxic activity after CNP
exposure (76.6% 17%; P 0.001), the amiC strain did not
exhibit significantly modified cytotoxicity in the presence of CNP
compared with controls (amiC strain without CNP exposure)
(14.7% 6.0%) (see Fig. S4C in the supplemental material). In
accordance with these data, we observed that the increased pro-
duction ofHCN triggered byCNPonwild-type PA14 disappeared
in the amiC mutant strain (Fig. S4D). It is interesting that the
strain overexpressing AmiC (AmiC) strongly lost its ability to
kill lung cells (Fig. S4A), confirming a role for AmiC in the regu-
lation of P. aeruginosa virulence.
DISCUSSION
We have shown that P. aeruginosa is sensitive to micromolar con-
centrations of natriuretic peptides (i.e., BNP and CNP) and re-
FIG6 Involvement of AmiC protein on P. aeruginosa biofilm formation. (A) 3D shadow representations of the biofilm structures developed by the P. aeruginosa
PA14 control (PA14), theamiC strain, and the amiC complemented strain (amiCComp), not exposed to peptide or exposed to CNP (107M) under dynamic
conditions, at 37°C for 24 h in LB broth. Biofilms were stained with SytoX and observed by confocal laser scanning microscopy. (B) COMSTAT analyses of
biofilms of P. aeruginosa PA14 control, the amiC strain, the amiC complemented strain, and the AmiC strain. (C) COMSTAT analyses of biofilms of the
P. aeruginosa PA14 control, the amiC strain, and the amiC complemented strain exposed to CNP (107 M), to BNP (107 M), or to neither of them. Data are
themeans for 27 samples from11 independent experiments for the PA14 control, 11 samples from four independent experiments for PA14 exposed toCNP, nine
samples from three independent experiments for PA14 exposed to BNP, 19 samples from seven independent experiments for the amiC control strain, 12
samples from four independent experiments for the amiC strain exposed to CNP, eight samples from three independent experiments for the amiC strain
exposed to BNP, 24 samples from six independent experiments for the amiC Comp control strain, and 12 samples from four independent experiments for the
amiC Comp strain exposed to CNP. Note that the values for the wild-type strain (left), amiC strain (middle), and amiC Comp strain (right) values are set to
100% independently. ***, P 0.001; *, P 0.05; NS, not significantly different.
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sponds to these eukaryotic factors by amajor increase in virulence
(16, 17). Previously, the intrabacterial cascade involving Vfr,
PtxR, RhlR, and LasR proteins, leading to a remodeling of the
lipopolysaccharide (LPS) structure and an increase of HCN and
exotoxin A production, was identified (16), but the nature of the
P. aeruginosa natriuretic peptide sensors remained a central ques-
tion.
P. aeruginosa is an opportunistic pathogen, and in cystic fibro-
sis patients, it is known to form biofilms in lung alveoli (2). As an
exchange surface between air and blood, the alveolar epithelium
formed by pneumocytes is particularly thin (0.2 m). If bacteria
develop on this epithelium, they are certainly exposed to diffusible
blood containing endocrine factors such as natriuretic peptides.
These are also produced locally by endothelial cells (22), by lung
airway epithelium cells, and by nonciliated Clara cells (19). The
growth of bacteria in biofilms is generally associated with a de-
crease of diffusible virulence factor synthesis (37). This assists in
establishing a chronic infectious status, which progressively weak-
ens the host, leading to a potential lethal outcome (3). Conversely,
an anticipated release of bacterial virulence factors, particularly
when the bacterium is not protected by the biofilm, should trigger
the host defense responses and the clearance of the pathogen and
increase antibiotic sensitivity. Due to the effect on biofilm forma-
tion in P. aeruginosa, CNP and relatedmolecules could potentially
be interesting for therapy. CNP strongly decreased the biofilm
formation activity of both P. aeruginosa PAO1 and PA14 strains,
confirming the hypothesis that virulence factor production and
biofilm formation are inversely related. This is consistent with our
previous results showing that CNP enhances cAMP production in
P. aeruginosa (17). Indeed, cAMP and c-di-GMP synthesis appear
to be antagonistically regulated in bacteria. While c-di-GMP pro-
motes the growth of biofilms (23), cAMP prevents P. aeruginosa
biofilm formation (38). The present results are also in agreement
with the observation that CNP induces a rearrangement of the
Pseudomonas LPS structure (17) and enhances algC mRNA syn-
thesis (16), since LPS contributes to bacterial surface properties
and AlgC is involved in synthesis of the LPS core (39).
In order to identify the potential natriuretic peptide sensor in
P. aeruginosa, we started from the hypothesis that this protein
should show structural homology with the binding domain of
eukaryotic natriuretic peptide receptors. van den Akker et al. (28)
have shown that the binding domain of the eukaryotic natriuretic
peptide receptor subtype A (NPR-A), a receptor which binds ANP
and BNP, exhibits a type I periplasmic binding protein fold and
that the closest structural neighbor of this ANP binding domain is
the AmiC protein from P. aeruginosa. Analysis of the crystal struc-
ture of the dimerized hormone binding domain of NPR-A and of
the structure of the AmiC-AmiR complex showed that in NPR-A
andAmiC, the same residues in helices3 and7 interact, respec-
tively, with ANP and AmiR. Furthermore, the pocket forming the
ANP binding site on NPR-A overlaps with the recognition site of
AmiR on AmiC (27, 28). In eukaryotes, NPR-A is known as a
receptor enzyme coupled to cGMP synthesis. However, CNP does
not lead to an increase of cGMP in P. aeruginosa, whereas it stim-
ulates cAMP synthesis (17). Then, we looked for possible similar-
ities between AmiC and human NPR-C (hNPR-C), the sole ANP
and CNP eukaryotic receptor coupled to an adenylate cyclase ac-
tivity (40). We observed in silico that hNPR-C and P. aeruginosa
AmiC proteins present 19% identity and 26% similarity, confirm-
ing the structural homology of eukaryotic natriuretic peptide re-
ceptors and AmiC (27). The AmiC binding domain helix 3 is
delineated by amino acids 85 to 99 (41). In the present study, we
noted that the binding of CNP to AmiC occurred in the same
region; 6 of the 13 CNP binding amino acids (Ala90, Met92,
Pro93, Glu96, Arg97, and Asp99) are in helix 3, suggesting that
CNP could compete with AmiR for binding on AmiC. We com-
pared all the amino acids putatively involved in the AmiC-CNP
interaction to those observed in the interaction of CNP with
NPR-C in eukaryotes (33). The physicochemical properties of
amino acids involved in these two interactions (i.e., CNP/AmiC in
bacteria and CNP/NPR-C in eukaryotes) showed a remarkably
high level of conservation (this study). We determined that AmiC
(likeNPR-C) (40) is functionally expressed as a dimer, reinforcing
the hypothesis that AmiC could have a CNP binding activity.
In P. aeruginosa, the amiC gene appears highly conserved
(99.57% sequence homology and total preservation of the amino
acid sequence between PAO1 and PA14 strains), suggesting that a
crucial role is played by this protein in this species. The amiC gene
is encoded in an operon including the amiL, amiE, amiB, amiC,
amiR, and amiS genes (36) (http://www.pseudomonas.com).
AmiC activation by acetamide, its classical ligand in bacteria, is
known to provoke the release of AmiR, leading to the transcrip-
tional activation of the whole ami operon (35, 41). We therefore
hypothesized that if CNP acts on AmiC in a fashion similar to that
of acetamide, it should also induce the ami operon expression.
This was confirmed by our observations. CNP actually induced
amiERC transcription, and the specificity of this action was rein-
forced by the lack of effect of BNPon the ami operon transcription
(data not shown). As mentioned elsewhere, P. aeruginosa AmiC
appears to be functionally related to hNPR-C, and it is interesting
that, in eukaryotic cells, NPR-C preferentially binds to CNP with
a higher affinity than to BNP (33). Such highly conserved specific
recognition modes between eukaryotic and bacterial sensors were
observed previously inHelicobacter pylori for the humanhormone
somatostatin, whose bacterial sensor can recognize only one ago-
nist subtype (42).
The issue of how CNP contacts AmiC in P. aeruginosa needs to
be addressed, as AmiC is predicted to be located in the bacterial
cytoplasm (http://www.pseudomonas.com). This means that
CNP must enter the bacterium before binding to AmiC. Such an
assumption is plausible, since another eukaryotic peptide, dynor-
phin, was shown able to freely cross the membrane of P. aerugi-
nosa, inducing increased virulence (14). This behavior was ex-
plained by the high percentage of basic and hydrophobic amino
acid residues present in dynorphin (76%) (43). Similarly, CNP
contains 73% basic or hydrophobic amino acids. Moreover, na-
triuretic peptides have been shown to form pores in phospholipid
bilayers (44) and could therefore manage their own entrance into
the bacterium. However, we cannot exclude the possibility that
AmiC protein could, under some conditions, reach the P. aerugi-
nosa inner membrane. Indeed, AmiC belongs to the type I
periplasmic binding fold protein family, and theUniprot database
claims that AmiC is located in the periplasmic space (http://
www.uniprot.org; reference P27017). One protein being located
in multiple bacterial compartments to undertake unrelated func-
tions is not unprecedented. Indeed, the EF-Tu protein, which acts
in the bacterial cytoplasm as a ribosomal elongation factor, was
shown to migrate upon stress to the plasma membrane and ac-
quire new functions as a sensor molecule (45). In P. aeruginosa,
EF-Tu, after migration into bacteria membrane, also behaves as a
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plasminogen-binding protein (46). To support this hypothesis,
we observed, using AmiC antibodies, that while AmiC protein is
mainly located in the bacterial cytosol, a proportion of AmiC is
associated with the inner membrane compartment (see Fig. S6 in
the supplemental material). In this case, we assumed that CNP is
delivered toAmiCproteins that have reached the innermembrane
through protein transporters, for example. To reinforce this hy-
pothesis, we observed that a protein encoded by the gene
PA14_64270 (ortholog of PA4858 in PAO1) possesses a high
structural similarity with AmiC, could virtually bind CNP, and is
necessary for the CNP effect on bacterial biofilm (see Fig. S5 in the
supplemental material).
Although six bacterial sensors for eukaryotic messengers
have been identified (6), to date, none of the bacterial sensors
structurally identified possesses similarity to the eukaryotic
counterpart receptor. For example, E. coli QseC, the sensor
protein for epinephrine, is a histidine sensor kinase which
crosses the bacterial membrane twice and which appears to be
structurally very different from the G-coupled protein receptor
(9, 47). In the same vein, gamma interferon, which binds the
eight-transmembrane-region P. aeruginosa OprF protein (48),
in mammals activates a single transmembrane receptor. Since
our data suggest that AmiC and hNPR-C possess a homologous
3D structure and that CNP acts as an agonist on P. aeruginosa,
we undertook to study the pharmacological profile of AmiC, as
happens in eukaryotic receptor studies.
Results from our pharmacological studies carried out using
cANF4-23, anNPR-C agonist, and isatin, anNPR-A/NPR-C antag-
onist (49) also support the hypothesis that AmiC acts as an or-
tholog of eukaryotic NPR-C. In silico molecular modeling re-
vealed that isatin binding to AmiC would require only 4 amino
acids, but, as expected for an antagonist, these amino acids are
located in the potential CNP binding pocket of AmiC. The antag-
onist effect of isatin was confirmed experimentally. Isatin had no
intrinsic activity on the biofilm formation activity of P. aeruginosa
but inhibited the effect of CNP. Conversely, the artificial peptide
cANF4-23, a specific NPR-C agonist in eukaryotes, was able to re-
produce the effects of CNP on P. aeruginosa global virulence on
lung cells, as observed byBlier et al. (16). These data reinforced the
hypothesis that AmiC acts as a sensor for natriuretic peptides but
do not exclude the possibility that these peptides bind to another
protein that in turn affects AmiC. In order to validate our hypoth-
esis, we purified P. aeruginosa AmiC recombinantly produced in
E. coli and checked the interactions of CNP, BNP, isatin, osteocrin
(an NPR-C agonist) (50), cANF4-23 (an NPR-C agonist), and
sANP (an NPR-A agonist) (51) with AmiC. As expected, AmiC
bound strongly to CNP, showing aKD of 2.0 0.3M, consistent
with the effective concentrations of CNP on P. aeruginosa. In con-
trast, BNP does not interact with AmiC, suggesting that BNP acts
on P. aeruginosa through another bacterial target, a hypothesis
strongly reinforced by the fact that BNP retains an effect on bio-
film formation in the amiCmutant strain (this study). Isatin also
showed a specific interaction, although at a significantly higher
concentration (600  200 M). As normal blood isatin concen-
trations are usually on the order of 0.3 to 1.3M(52), this implies
that in vivo, isatin is unlikely to be at a sufficiently high concen-
tration to antagonize the effects of CNP on AmiC. Finally, we
attempted to test specific agonists of NPR-A and NPR-C, to con-
firm that AmiC reflects NPR-C specificity. sANP showed some
interaction with AmiC, but this interaction was weak and indeed
was not complete at the highest ligand concentration available,
indicating a KD (likely considerably) in excess of 600 M, proba-
bly explaining the weak effect of this peptide on bacterial cytotox-
icity (this study). In contrast, initial experiments on osteocrin
showed that it bound sufficiently strongly that it was beyond the
limit of detection of our experiment (100 nM), and cANF4-23 pos-
sesses a KD in the same range as that of CNP. These observations
suggest that AmiC does indeed show the same specificity as
NPR-C and is selective against NPR-A agonists. Finally, using an
amiC-deficient mutant strain and its complemented derivative,
we physiologically validated the crucial role of AmiC sensor in
CNP effects on P. aeruginosa virulence expression and biofilm
formation.
The last puzzling question is the reason why a bacterium such as
P. aeruginosa should express a sensor system for peptides which are
naturally labilemoleculespresentonly invertebrates.The fact that the
CNP sensor should also be a binding site for isatin provides some
clues on a possible explanation. Isatin, or indole-2,3-dione, is an in-
terspecies signal molecule produced in large amounts by bacteria
such as Escherichia coli (53). Until now, pseudomonads were not
thought to synthesize isatin or isatin-related compounds, but as
shown by Lee et al. (54) and in the present study, P. aeruginosa can
detect thismolecule. Isatin is alsoproduced in large amounts byplant
tissues, where it is a precursor in auxin biosynthesis (55), and by
mammalian tissues, including lungs (56, 57). Therefore, in the host,
P. aeruginosa is regularly exposed to significant amounts of isatin. As
is the case for GABA (15), it will gain an advantage by adapting its
behavior in response to the host physiology.Nevertheless, even if this
explanation is correct, the fact that AmiC showed common proper-
tieswith the eukaryoticNPR-C, includingCNP recognition, remains
to be explained.
In conclusion, the present work provides the first demonstra-
tion that bacteria not only are sensitive to eukaryotic messengers
but also could express eukaryotic receptor-like structures to detect
human hormones. The AmiC sensor protein acts as an ortholog of
the eukaryotic receptor NPR-C, acting as a CNP/isatin sensor in
P. aeruginosa that modulates bacterial biofilm formation. Since
the CNP hormone is produced in the lung, the effects of CNP on
the biofilm formation activity of P. aeruginosa could represent a
natural defense mechanism against lung colonization. Further-
more, a natriuretic peptide receptor agonist has been used as a
bronchodilator drug (58). On one hand, this could pose a risk of
enhancing P. aeruginosa virulence, and on the other, it may pre-
vent biofilm formation. This opens up the tantalizing prospect
that compounds in development for other indications could be
retargeted for use against biofilms.
MATERIALS AND METHODS
Reagents and test substances.The CNP peptide was obtained fromPoly-
peptide (Strasbourg, France). Isatin and hBNP were purchased from
Sigma-Aldrich (St Quentin Fallavier, France). Osteocrin, sANP, and
cANF4-23 were synthesized by J. Leprince (PRIMACEN platform, Univer-
sity of Rouen, France). Dimethyl sulfoxide (DMSO) was purchased from
Acros Organics (Geel, Belgium).
Bacterial strains and bacterial cultures. Pseudomonas aeruginosa
PAO1 was obtained from an international collection (17). P. aeruginosa
MPAO1 was originally from the Iglewski lab. A transposon library was
constructed from theMPAO1 strain at theUniversity ofWashington (59).
The P. aeruginosa PA14 was from Harvard Medical School (Boston, MA)
(60) and kindly provided by the Biomerit Research Center (University
Cork, Ireland). All strains used in this work are listed in Table S2 in the
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supplemental material. All strains were grown at 37°C in Luria Bertani
medium (LB). For treatment with CNP, an overnight culture was diluted
to an optical density at 600 nm (OD600) of 0.08 using a ThermoSpectron-
ics (Cambridge, United Kingdom) spectrophotometer. CNP was added
2 h after the onset of the culture, a time corresponding to themiddle of the
exponential growth phase. For all studies performed using isatin, because
of its hydrophobicity, this molecule was initially dissolved in a solution of
DMSO in water (5/95). The final concentration of DMSO in bacterial
culture medium was kept under 0.2%. In this case, control experiments
were conducted in the presence of the same final concentration of DMSO.
The final bacterial density and the absence of contamination were con-
trolled by plating.
Biofilm formationunder dynamic conditions.After 3 h of preculture
in LB at 37°C, P. aeruginosaPA14was inoculated at anOD600 of 0.08 in LB
medium and subcultured for 2 h. CNP (1 M final concentration) was
added, and bacteria were grown for additional 3 h. Bacteria were then
washed and adjusted to an OD600 of 0.1 in 0.9%NaCl supplemented with
CNP (1 M). The bacterial suspensions were then used to study biofilm
formation under dynamic conditions at 37°C in a three-channel flow cell
as described by Bazire et al. (61). Briefly, each bacterial suspension was
injected into a flow cell channel, and bacteriawere allowed to adhere to the
glass coverslip for 2 h. A flow (2.5 ml/h) of LB medium containing CNP
(1 M) was then applied for 24 h. At the end of the experiments, the
biofilms were stained with 5 M Syto 61 red dye or 5 M SytoX (Molec-
ular Probes). Observations were made using a confocal laser scanning
microscope (LSM 710 confocal laser-scanning microscope; Zeiss). The
biofilm thicknesses and corresponding biovolumes were estimated by
measuring field samples from at least 3 independent experiments using
COMSTAT software (62).
Biofilm formation under static conditions. The static bacterial bio-
film formation activity was determined after 24 h of development. Precul-
tures of P. aeruginosa, containing the pSMC2.1 plasmid harboring the
green fluorescent protein (GFP) gene, were grown overnight at 37°C. An
aliquot of preculture (100 l) was then added to 5 ml of LB medium
supplemented with 400 g/ml kanamycin. Tested molecules or the cor-
responding excipient were added after 2 h of subculture. Three hours
later, bacteria were collected by centrifugation (7,000  g, 10 min). The
supernatant was then removed, and the pellets were resuspended in 25ml
of physiological solution (0.9% NaCl) and adjusted to an OD600 of 0.1.
Sterile glass slides, previously cleaned with 4% TFD4 in water (Dutscher,
Brumath, France), were layered in petri dishes and covered by the bacte-
rial suspension. The slides were then incubated for 2 h at 37°C under static
conditions. At the end of the attachment period, the physiological solu-
tion was replaced by LB medium and incubated for 24 h at 37°C in static
condition. The slides were then rinsed twice in 25 ml sterile phosphate-
buffered saline (PBS; 0.1 M; pH 7.4), and bacteria were heat fixed. Bio-
filmswere observed using a confocal laser scanningmicroscope (LSM710;
Zeiss). Images were treated using a 3-median filter and segmented using
Zen 2009 software (Zeiss). The volumes and thicknesses of the biofilms
were estimated as described elsewhere (62). All 2D images are represen-
tative of 15 observations.
In silico studies. STAMP software (31) was used within VMD (63) on
a single computer. GASH structural superposition software (32) was used
on the web server (http://sysimm.ifrec.osaka-u.ac.jp/gash/). Potential li-
gand/protein interactions were investigated in silico by the molecular
docking technique using the amidase sensor protein of P. aeruginosa
AmiC (PDB ID: 1QO0). Essential hydrogen atoms, Kollman united atom
type charges, and solvation parameters were added with the aid of
AutoDock tools (34). Affinity (grid) maps of 20- by 20- by 20-Å grid
points and 0.375-Å spacing were generated using the Autogrid program
(34). AutoDock parameter set- and distance-dependent dielectric func-
tions were used in the calculation of the van derWaals and electrostatic
terms, respectively. Docking simulations were made using the La-
marckian genetic algorithm (LGA). Initial position, orientation, and
torsions of the ligand molecules were set randomly. Each docking
experiment was derived from three different runs that were set to
terminate after a maximum of 1,000,000 energy evaluations. The pop-
ulation size was set to 100.
qRT-PCRmRNA assays. RNA extraction and quantification were re-
alized as previously described (61) using bacteria grown for 3 h in LB. The
primers employed are presented in Table S3 in the supplementalmaterial.
The transcription level of 16S rRNA was used as the endogenous control.
PCRs were performed in triplicate, and the standard deviations were
lower than a CT (cycle threshold) of 0.15. Relative quantification of
mRNAwas obtained according to Bazire et al. (64) using the comparative
CT (2CT) method (65).
Lung epithelial cell cytotoxicity tests. The human A549 lung epithe-
lial cell type II line (ATCC-CCL185TM) (American Type Culture Collec-
tion, Manassas, VA) was grown at 37°C in 5% CO2 atmosphere in Dul-
becco’s modified Eagle’s medium (DMEM; Lonza) supplemented with
10% fetal calf serum (Lonza) and 1% of penicillin and streptomycin (Pe-
nistrep; Lonza). For cytotoxicity assays, cells were seeded in 24-well plates
at a final density of 3 105 cells per well and grown for 48 h before use. A
minimumof 24 h before infection assays, cells were deprived of antibiotics
and fetal calf serum by the addition of a fresh serum- and antibiotic-free
medium. For the assays, A549 cells were incubated for 2 h with control or
pretreated P. aeruginosa PA14 at amultiplicity of infection of 10. Bacterial
cytotoxicity was determined by measurement of lactate dehydrogenase
(LDH) release. LDH is a stable cytosolic enzyme that diffuses into the
culture medium upon cell lysis. This marker of cytotoxicity was assayed
using the Cytotox 96 enzymatic assay (Promega, Charbonnières, France)
as previously described (17).
P. aeruginosa AmiC purification. To express P. aeruginosa AmiC in
E. coli, a synthetic codon-optimized gene was prepared (MWG Operon)
with a leader sequence of MHHHHHHSSGVDLGTENLYFQS to provide
a cleavable 6His tag. This was cloned into the NcoI and HindIII restric-
tion sites of the pET-Duet1 vector (Novagen). This construct was trans-
formed into Rosetta2 (DE3) cells (Novagen) and grown in 500 ml of
ZYM-5052 medium (66) at 37°C until mid-log phase and then at 20°C
overnight. Cells were harvested by centrifugation at 4,750 g for 30 min,
and resuspended in 20 mM Tris-HCl, 0.5 M NaCl, 20 mM imidazole
(pH 8.0) (buffer A). Cells were lysed using a sonicator and clarified by
centrifugation at 20,000 g. The protein was purified using a 1-ml His-
Trap crude FF column and a Superdex 200 16/600 high-resolution col-
umn (GE Healthcare), using an ÄKTAxpress system (GE Healthcare) at
4°C. Lysate was loaded over the IMAC column at 0.25 ml min1 and
washed with buffer A. AmiC was eluted in buffer A supplemented with
250 mM imidazole (pH 8.0) and loaded onto the gel filtration column.
The protein was then eluted isocratically in 10 mMHEPES-NaOH, 0.5 M
NaCl (pH 7.0). DMSO was added to the purified protein to 1% (vol/vol),
and the protein was concentrated using a Vivaspin 20 centrifugal concen-
trator (Sartorius; 10-kDa molecular mass cutoff) at 4°C.
Microscale thermophoresis. AmiC was labeled using the RED-NHS
labeling kit (NanoTemper Technologies). The labeling reaction was per-
formed according to the manufacturer’s instructions in the supplied la-
beling buffer applying a concentration of 20 M protein (molar dye-to-
protein ratio ~ 2:1) at room temperature for 30 min. Unreacted dye was
removed with the supplied dye removal columns equilibrated with
MicroScale thermophoresis (MST) buffer (50 mM Tris-HCl [pH 7.5],
150 mM NaCl, 10 mM MgCl2). The label/protein ratio was determined
using photometry at 650 and 280 nm. Typically, a ratio of 0.8 was
achieved.
AmiC, either labeled (CNP, isatin, BNP, and cANF4-23) or unlabeled
(sANP and osteocrin), was adjusted to 100 nM with MST buffer supple-
mented with 0.05% Tween 20. CNP, isatin, sANP, and osteocrin were
dissolved in MST buffer supplemented with 0.05% Tween 20. A series of
1:1 dilutions were prepared in the identical buffer, producing ligand con-
centrations ranging from 13 nM to 434 M (CNP), 3.12 M to 3 mM
(isatin), 892 nM to 1.8 mM (sANP), 28 nM to 450 M (BNP), 68 nM to
1.1 mM (cANF4-23), and 120 pM to 4 M (osteocrin). For thermophore-
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sis, each ligand dilution wasmixed with 1 volume of AmiC, which leads to
a final concentration of AmiC of 50 nM and final ligand concentrations at
half of the ranges above. After a 5-min incubation, followed by centrifu-
gation at 10,000 g for 10 min, approximately 4 l of each solution was
filled into Monolith NT standard treated capillaries (NanoTemper Tech-
nologies GmbH). Thermophoresis was measured using a Monolith
NT.115 or Monolith NT.LabelFree instrument (NanoTemper Technolo-
gies GmbH) at an ambient temperature of 25°C with 5-s/30-s/5-s laser
off/on/off times, respectively. Instrument parameters were adjusted
with 50% LED power and 20 to 40% MST power. Data from three
independently pipetted measurements were analyzed (NT.Analysis
software version 1.5.41; NanoTemper Technologies) using the signal
from thermophoresis and temperature jump. Following data analysis,
the thermophoresis signals were fitted to the formula for KD from the
law of mass action:
f(c) unbound
(bound unbound)[AmiC] c KD([AmiC] c KD)2 (4 [AmiC] c)
2 [AmiC]
where f(c) is the observed thermophoresis signal, “unbound” is the
signal in the absence of ligand (normalized to 0), “bound” is the signal
at infinite ligand concentration, c is the concentration of ligand in the
same units as AmiC concentration, and KD is the dissociation con-
stant. The data were fitted using GraphPad Prism version 5, and figures
for thermophoresis were generated using this software. For cANF4-23,
incubation with AmiC resulted in a dose-dependent increase in AmiC
fluorescence, which confounds the MST signal. This increase was
therefore measured using the MST device, and the data were fitted to
the above equation. To confirm that the fluorescence increase was
related to binding, samples were heated to 95°C for 10 min with 2%
(wt/vol) SDS and 20 mM dithiothreitol (DTT) and retested: addition
of cANF4-23 no longer increased fluorescence.
Statistical analysis. The nonparametric Mann-Whitney test was used
to compare the means within the same set of experiments.
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